R Thomas Jagoe is an expert in Oncology at Jewish General Hospital (Canada). R Thomas Jagoe has authored 42 publications, the most recent in 2026. SLR score: 137 (community average: 125). How the SLR is computed.

LeadR Profile

R Thomas Jagoe Jewish General Hospital Canada
137 ScienceLeadR Reputation 137
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Jewish General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 42

Citations

Citations: 7 795 1st author: 6 Last author: 16 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The gut microbiome and dietary interventions in cancer cachexia.
PMID 41607234 — neoplasms, diet, gastrointestinal microbiome, cachexia, cancer-associated cachexia
Curr Opin Clin Nutr Metab Care20260
Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia.
PMID 40325598 — neoplasms, weight loss, therapeutics, gastrointestinal microbiome, cachexia, sarcopenia, cancer-associated cachexia
J Cachexia Sarcopenia Muscle20250
Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study.
PMID 38370474 — pilot projects, research design, pilots, cytochrome p-450 enzyme system, blood, pharmaceutical preparations, cytochrome p-450 cyp1a2, diet, drug-related side effects and adverse reactions, enzymes, precision medicine, therapeutics, pharmacokinetics
Front Pharmacol20241
Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle.
PMID 39516566 — muscles, neoplasms, immunotherapy, therapeutics, gastrointestinal microbiome
BJC Rep20234
Chronic aryl hydrocarbon receptor activity phenocopies smoking-induced skeletal muscle impairment.
PMID 34725955 — pulmonary disease, chronic obstructive, smoking, hydrocarbons, ligands, smoke, muscle, skeletal, muscular atrophy, genes, cachexia, sarcopenia, muscle fibers, skeletal, muscles, neuromuscular junction, down-regulation, receptors, aryl hydrocarbon
J Cachexia Sarcopenia Muscle202125

LeadR Networks

Main global connection map